ALS Association: The Lawrence and Isabel Barnett Drug Development

especially interested in drug discovery projects supporting the following:

• In vivo efficacy testing of therapeutic candidates (pharmacological treatments, biological therapies, or gene therapy) in models of ALS.
• Studies on pharmacokinetics, pharmacodynamics, preclinical toxicology/safety (ADME/Tox), dose-range finding, and target engagement.
• Other IND enabling studies

 Funding: $250,000/year for 2 years.

Overhead 10%.

https://www.als.org/research/funding-opportunities/lawrence-and-isabel-barnett-drug-development-program-2022